JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A4472 Mdivi 1
1 Citation

Summary: Selective DRP1/Dnm1 inhibitor, cell-permeable

insoluble in H2O; insoluble in EtOH; ≥17.65 mg/mL
A8212 PR-619

Target: Deubiquitinating enzymes (DUBs)

Summary: Deubiquitylating enzymes (DBUs) inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.15 mg/mL
A8222 BX795
2 Citation

Summary: PDK1 inhibitor

≥59.1 mg/mL
A8254 SB 203580
38 Citation

Target: p38|PKB

Summary: P38 MAP kinase inhibitor

insoluble in H2O; ≥18.872 mg/mL
A2917 Flumazenil
1 Citation

Target: GABAA Receptors

Summary: Benzodiazepine antagonist

insoluble in H2O; insoluble in EtOH; ≥30.38 mg/mL
A1984 Bendamustine HCl

Summary: Cytostatic agent for non-Hodgkin lymphomas
A2877 Camptothecin
5 Citation

Target: Topoisomerases

Summary: Topoisomerase I inhibitor,prototypic

insoluble in H2O; insoluble in EtOH; ≥8.7 mg/mL
A2813 Ivermectin
2 Citation

Summary: NAChR/purinergic P2X4 receptor modulator

≥43.75 mg/mL
A1877 XAV-939
16 Citation

Target: TNKS

Summary: Tankyrase 1/2 (TNKS) inhibitor

insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
A2548 Carmofur

Summary: Cytostatic derivative of fluorouracilm,antineoplatic agent